Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04473599 · ClinicalTrials.gov registry record · NA

Stay Well at Home: a Text-messaging Study Social Distancing

A NA study, sponsored by University of California, Berkeley.

Completed
Registry status
NA
Development phase
1,000
Enrollment target

NCT04473599 is a NA study that has completed, run by University of California, Berkeley. The registered enrollment target is 1,000 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04473599, a NA study, has completed, sponsored by University of California, Berkeley.

COMPLETED
Registry status
NA
Development phase
1,000 participants
Enrollment target

Study Summary

The investigators have developed supportive text-messages in English and Spanish to help people cope with the stress and anxiety of COVID-19 social distancing. The purpose of this study is to examine if automated text-messages will improve depression and anxiety symptoms and enhance positive mood. Additionally, the investigators will compare the effectiveness of sending messages on a random schedule (using a micro-randomized trial design) or sent by a reinforcement learning policy on overall change in depression and anxiety symptoms and daily mood during the 8-week study.

Interventions

  • BEHAVIORAL Uniform random message delivery
  • BEHAVIORAL Reinforcement learning message delivery
  • BEHAVIORAL Mood ratings only

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2020-04-17
Est. Completion 2023-01-10
Phase NA

Sponsor

University of California, Berkeley

72 total trials

What the Registry Record Tells You About NCT04473599

The ClinicalTrials.gov registry entry for NCT04473599 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Uniform random message delivery is the first listed.

NCT04473599 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04473599 about?

NCT04473599 is a clinical study titled "Stay Well at Home: a Text-messaging Study Social Distancing". The investigators have developed supportive text-messages in English and Spanish to help people cope with the stress and anxiety of COVID-19 social distancing. The purpose of this study is to examine if automated text-messages will improve depression and anxiety symptoms and enhance positive mood. ...

What is the current status of trial NCT04473599?

This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2020-04-17. Estimated completion is 2023-01-10.

What interventions are being tested in trial NCT04473599?

The interventions under investigation include: Uniform random message delivery (BEHAVIORAL), Reinforcement learning message delivery (BEHAVIORAL), Mood ratings only (BEHAVIORAL).

Who is sponsoring clinical trial NCT04473599?

This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.